Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells

BACKGROUND: 209 000 new cases of renal carcinoma are diagnosed each year worldwide and new therapeutic targets are urgently required. The great majority of clear cell renal cancer involves inactivation of VHL, which acts as a gatekeeper tumour suppressor gene in renal epithelial cells. However how V...

Descripción completa

Detalles Bibliográficos
Autores principales: Harten, Sarah K, Esteban, Miguel A, Shukla, Deepa, Ashcroft, Margaret, Maxwell, Patrick H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155908/
https://www.ncbi.nlm.nih.gov/pubmed/21791076
http://dx.doi.org/10.1186/1476-4598-10-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155908/
https://www.ncbi.nlm.nih.gov/pubmed/21791076
http://dx.doi.org/10.1186/1476-4598-10-89

Ejemplares similares